Abstract
Summary
Risperdal (generic name risperidone) is an antipsychotic drug prescribed to treat schizophrenia, bipolar disorder and some behavioral problems in children with autism. It works by changing the effects of chemicals in the brain. It rebalances dopamine and serotonin to potentially improve mood, behavior and thinking.
LPI (LP Information)' newest research report, the “Risperidone Industry Forecast” looks at past sales and reviews total world Risperidone sales in 2022, providing a comprehensive analysis by region and market sector of projected Risperidone sales for 2023 through 2029. With Risperidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Risperidone industry.
This Insight Report provides a comprehensive analysis of the global Risperidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Risperidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Risperidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Risperidone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Risperidone.
The global Risperidone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Risperidone players cover Pharaonia Pharmaceuticals, Aurobindo Pharma, Wellona Pharma, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Amneal Pharmaceuticals and Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Risperidone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Solution
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Risperidone market?
What factors are driving Risperidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Risperidone market opportunities vary by end market size?
How does Risperidone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Risperidone Industry Forecast” looks at past sales and reviews total world Risperidone sales in 2022, providing a comprehensive analysis by region and market sector of projected Risperidone sales for 2023 through 2029. With Risperidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Risperidone industry.
This Insight Report provides a comprehensive analysis of the global Risperidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Risperidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Risperidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Risperidone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Risperidone.
The global Risperidone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Risperidone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Risperidone players cover Pharaonia Pharmaceuticals, Aurobindo Pharma, Wellona Pharma, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Amneal Pharmaceuticals and Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Risperidone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Solution
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Risperidone market?
What factors are driving Risperidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Risperidone market opportunities vary by end market size?
How does Risperidone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Risperidone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Risperidone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Risperidone by Country/Region, 2018, 2022 & 2029
2.2 Risperidone Segment by Type
2.2.1 Tablets
2.2.2 Solution
2.2.3 Others
2.3 Risperidone Sales by Type
2.3.1 Global Risperidone Sales Market Share by Type (2018-2023)
2.3.2 Global Risperidone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Risperidone Sale Price by Type (2018-2023)
2.4 Risperidone Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Risperidone Sales by Application
2.5.1 Global Risperidone Sale Market Share by Application (2018-2023)
2.5.2 Global Risperidone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Risperidone Sale Price by Application (2018-2023)
3 Global Risperidone by Company
3.1 Global Risperidone Breakdown Data by Company
3.1.1 Global Risperidone Annual Sales by Company (2018-2023)
3.1.2 Global Risperidone Sales Market Share by Company (2018-2023)
3.2 Global Risperidone Annual Revenue by Company (2018-2023)
3.2.1 Global Risperidone Revenue by Company (2018-2023)
3.2.2 Global Risperidone Revenue Market Share by Company (2018-2023)
3.3 Global Risperidone Sale Price by Company
3.4 Key Manufacturers Risperidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Risperidone Product Location Distribution
3.4.2 Players Risperidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Risperidone by Geographic Region
4.1 World Historic Risperidone Market Size by Geographic Region (2018-2023)
4.1.1 Global Risperidone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Risperidone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Risperidone Market Size by Country/Region (2018-2023)
4.2.1 Global Risperidone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Risperidone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Risperidone Sales Growth
4.4 APAC Risperidone Sales Growth
4.5 Europe Risperidone Sales Growth
4.6 Middle East & Africa Risperidone Sales Growth
5 Americas
5.1 Americas Risperidone Sales by Country
5.1.1 Americas Risperidone Sales by Country (2018-2023)
5.1.2 Americas Risperidone Revenue by Country (2018-2023)
5.2 Americas Risperidone Sales by Type
5.3 Americas Risperidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Risperidone Sales by Region
6.1.1 APAC Risperidone Sales by Region (2018-2023)
6.1.2 APAC Risperidone Revenue by Region (2018-2023)
6.2 APAC Risperidone Sales by Type
6.3 APAC Risperidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Risperidone by Country
7.1.1 Europe Risperidone Sales by Country (2018-2023)
7.1.2 Europe Risperidone Revenue by Country (2018-2023)
7.2 Europe Risperidone Sales by Type
7.3 Europe Risperidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Risperidone by Country
8.1.1 Middle East & Africa Risperidone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Risperidone Revenue by Country (2018-2023)
8.2 Middle East & Africa Risperidone Sales by Type
8.3 Middle East & Africa Risperidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Risperidone
10.3 Manufacturing Process Analysis of Risperidone
10.4 Industry Chain Structure of Risperidone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Risperidone Distributors
11.3 Risperidone Customer
12 World Forecast Review for Risperidone by Geographic Region
12.1 Global Risperidone Market Size Forecast by Region
12.1.1 Global Risperidone Forecast by Region (2024-2029)
12.1.2 Global Risperidone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Risperidone Forecast by Type
12.7 Global Risperidone Forecast by Application
13 Key Players Analysis
13.1 Pharaonia Pharmaceuticals
13.1.1 Pharaonia Pharmaceuticals Company Information
13.1.2 Pharaonia Pharmaceuticals Risperidone Product Portfolios and Specifications
13.1.3 Pharaonia Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pharaonia Pharmaceuticals Main Business Overview
13.1.5 Pharaonia Pharmaceuticals Latest Developments
13.2 Aurobindo Pharma
13.2.1 Aurobindo Pharma Company Information
13.2.2 Aurobindo Pharma Risperidone Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aurobindo Pharma Main Business Overview
13.2.5 Aurobindo Pharma Latest Developments
13.3 Wellona Pharma
13.3.1 Wellona Pharma Company Information
13.3.2 Wellona Pharma Risperidone Product Portfolios and Specifications
13.3.3 Wellona Pharma Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Wellona Pharma Main Business Overview
13.3.5 Wellona Pharma Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Risperidone Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Information
13.5.2 Janssen Pharmaceuticals Risperidone Product Portfolios and Specifications
13.5.3 Janssen Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Janssen Pharmaceuticals Main Business Overview
13.5.5 Janssen Pharmaceuticals Latest Developments
13.6 Amneal Pharmaceuticals
13.6.1 Amneal Pharmaceuticals Company Information
13.6.2 Amneal Pharmaceuticals Risperidone Product Portfolios and Specifications
13.6.3 Amneal Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amneal Pharmaceuticals Main Business Overview
13.6.5 Amneal Pharmaceuticals Latest Developments
13.7 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
13.7.1 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Company Information
13.7.2 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Product Portfolios and Specifications
13.7.3 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Main Business Overview
13.7.5 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Latest Developments
14 Research Findings and Conclusion